Combination of Pentostatin, Bendamustine and Ofatumumab for Treatment of Chronic Lymphocytic Leukemia and Lymphoma

Clinical trial NCT01352312 · TERMINATED

Trial details

NCT number

NCT01352312

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Status

TERMINATED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2011-05-25

Primary completion

2016-04-08

Enrollment

10

View on ClinicalTrials.gov